Related Experiment Video
Updated: Apr 4, 2026

07:07
Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
Published on: May 2, 2017
14.5K
Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data
Michele Schiavon1, Chiara Dalla Man1, Simmi Dube2
11 Department of Information Engineering, University of Padova , Padova, Italy .
Diabetes Technology & Therapeutics
|August 28, 2015
Summary
We developed a two-compartment model to precisely estimate the plasma-to-interstitial fluid glucose equilibration time in healthy and type 1 diabetes mellitus (T1DM) subjects, crucial for subcutaneous glucose sensor accuracy.
Area of Science:
- Biomedical Engineering
- Metabolic Research
- Diabetes Technology
Background:
- Accurate glucose monitoring is vital for type 1 diabetes mellitus (T1DM) management.
- Subcutaneous glucose sensors are essential for open- and closed-loop therapeutic systems.
- Understanding plasma-to-interstitial fluid (ISF) glucose dynamics and delay is critical for sensor accuracy.
Purpose of the Study:
- To develop a kinetic model of plasma-to-ISF glucose transfer.
- To estimate the plasma-to-ISF glucose delay in healthy and T1DM individuals.
- To utilize multitracer and microdialysis data for kinetic modeling.
Main Methods:
- Employed a specific experimental design with multiple tracers and microdialysis.
- Collected simultaneous plasma and ISF glucose data frequently.
- Applied linear time-invariant compartmental modeling to steady-state tracer data.
Main Results:
- A two-compartment model accurately described plasma and ISF glucose kinetics.
- Calculated median plasma-to-ISF glucose equilibration times: 9.1 min (healthy) and 11.0 min (T1DM).
- Demonstrated precise estimation of the "equilibration time".
Conclusions:
- Plasma-to-ISF glucose kinetics in steady-state can be modeled using a linear two-compartment model.
- The "equilibration time" between plasma and ISF glucose can be accurately estimated.
- Future research will investigate kinetics during glucose/insulin perturbations.

